Acutus Medical Inc 2024年度报告

SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549____________________________ (Mark one) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year endedDecember31, 2024OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromtoCommission File Number001-39430__________________________________ ACUTUS MEDICAL, INC.(Exact name of Registrant as specified in its charter)__________________________________ 45-1306615 (State or other jurisdiction ofincorporation or organization) (I.R.S.EmployerIdentification No.) 2210 Faraday Ave.,Suite 100,Carlsbad,CA(Address of principal executive offices) 92008(Zip Code) (Registrant’s telephone number, including area code) (442)232-6080___________________________________________ Securities registered pursuant to Section12(b) of the Act: None1 Securities registered pursuant to Section 12(g) of the Act:NoneIndicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule405 of the Securities Act.Yes¨Nox Indicate by check mark if the Registrant is not required to file reports pursuant to Section13 or 15(d) of the Act.Yes¨Nox Indicate by check mark whether the Registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)has been subject to such filingrequirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit suchfiles).Yes☒No☐ Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the Registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internalcontrol over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm thatprepared or issued its audit report.¨ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the Registrant included in thefiling reflect the correction of an error to previously issued financial statements.¨ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation receivedby any of the Registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).¨ Indicate by check mark whether Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ The aggregate market value of the common stock held by non-affiliates of the Registrant, based on the closing price of $0.036 per share of the Registrant’scommon stock on June 28, 2024, the last business day of the Registrant’s most recently completed second fiscal quarter, as reported by the OTC PinkMarket on such date, was approximately $1.1million . For purposes of calculating the aggregate market value of shares held by non-affiliates, we haveassumed that all outstanding shares are held by non-affiliates, except for shares owned by each of our executive officers, directors and 5% or greaterstockholders. In the case of 5% or greater stockholders, we have not deemed such stockholders to be affiliates unless there are facts and circumstancesindicating that such stockholders exercise any control over our company. This calculation does not reflect a determination that certain persons are affiliatesof the Registrant for any other purpose. On March17, 2025, there were29,912,305shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE None. Auditor Name:KPMG LLPAuditor Location:San Diego, CaliforniaAuditor Firm ID:185 On May 16, 2024, the Nasdaq Stock Market LLC filed a Form 25 to delist our common stock and remove such securities from registration under Section12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and such delisting took effect on May 26, 2024. The deregistration of ourcommon stock under Section 12(b) of the Exchange Act was effective 90 days after the Form 25 filing. Ou